Genome Mining for Novel Biocatalysts

Service Scope

When Genome Mining Is Appropriate

Genome mining is appropriate when the target activity is likely to be associated with known protein families, conserved catalytic residues, domain architectures, or sequence motifs. It can also be used to build a candidate panel for expression testing, enzyme engineering, or application-specific screening.

• Discovery of new hydrolases, oxidoreductases, transferases, lyases, or isomerases.
• Candidate selection from public genomes, metagenomes, or client-owned datasets.
• Expansion of an internal enzyme collection before wet-lab validation.
• Comparison of homologs from different source organisms or environments.
• Selection of candidates with sequence novelty or predicted condition tolerance.

Analysis Workflow

Candidate Prioritization Criteria

Candidate prioritization is adjusted to the project. For a discovery project, sequence novelty may be weighted more strongly. For an application project, predicted expression feasibility, substrate relevance, and known family behavior may be more important.

• Sequence similarity to characterized enzymes.
• Presence and integrity of conserved catalytic residues.
• Domain architecture and possible truncations.
• Source organism or environmental context.
• Predicted secretion signal, transmembrane region, or solubility concern when relevant.
• Feasibility of synthesis, cloning, expression, and activity testing.

How Genome Mining Results Should Be Interpreted

Genome mining results are best interpreted as a structured hypothesis about enzyme function. A strong candidate may have a convincing family assignment, intact catalytic residues, and a source environment that matches the desired property, but it still needs experimental testing. A lower-confidence candidate may still be useful when the project values novelty or broad sequence diversity.

For this reason, the final candidate set is usually not limited to one “best” sequence. A practical shortlist often includes high-confidence homologs, more distant homologs, and candidates selected for environmental relevance. This gives the validation stage enough diversity to avoid depending on a single prediction.

Recommended Follow-Up Options

After candidate selection, the next step depends on project risk and budget. Some clients move directly to candidate gene synthesis, expression, and validation for a small shortlist. Others first request deeper annotation, phylogenetic grouping, or removal of redundant candidates. For application-driven projects, it is useful to connect candidate selection with an assay plan before synthesis begins.

Quality Control for the Mining Output

A genome mining report should make it clear how candidates were found and why they were retained. Useful quality-control checks include removal of incomplete or duplicated sequences, review of unusually short or long ORFs, confirmation that key domains are present, and flagging of candidates with possible transmembrane regions or expression concerns. These checks help prevent resources from being spent on candidates that are unlikely to be testable.

For larger datasets, candidate clustering can also be helpful. Clustering reduces redundancy and makes it easier to choose representatives from different branches of sequence space. This is especially useful when the goal is to build a diverse expression panel rather than simply select the closest homologs. For data-heavy projects, metagenomic enzyme annotation and prioritization can be used as a focused follow-up step.

Deliverables

• Input data assessment and analysis plan.
• Candidate enzyme sequence list.
• Functional annotation and domain summary.
• Motif or catalytic residue review where applicable.
• Candidate ranking table with selection rationale.
• Recommendations for gene synthesis, expression, purification, and activity validation.

Information Needed for Quotation

• Target enzyme family or reaction type.
• Sequence data type and file format, or public dataset accession.
• Desired property profile, substrate class, or source environment.
• Expected number of candidates, if known.
• Need for downstream expression or activity validation.

Request Genome Mining Support

FAQs About Genome Mining for Novel Biocatalysts

• Q: Can public genome or metagenome datasets be used?

  A: Yes. Public datasets can be used if they are relevant to the target enzyme family, source environment, or desired property. Dataset quality and metadata should be reviewed before analysis.

• Q: What is the difference between genome mining and functional screening?

  A: Genome mining identifies candidates from sequence information. Functional screening identifies hits based on measurable activity. Genome mining is faster when sequence markers are reliable, while functional screening is useful when activity evidence is required early.

• Q: Can candidate sequences be validated after mining?

  A: Yes. Candidate genes can be synthesized, cloned, expressed, purified, and tested for activity when validation is included in the project scope.

• Q: Does genome mining guarantee an active enzyme?

  A: No. Sequence analysis can prioritize candidates, but activity depends on expression, folding, substrate compatibility, assay conditions, and whether the predicted function is correct.